The current situation has placed in debate if the Peruvian Economic Constitution enables the state intervention in the medicine market as a solution to the public problem of the increase of prices of pharmaceutical products in the context of the Covid. In this sense, the legislative initiatives that proposed various alternatives for solution are analyzed, among them, the regulation of medicine prices; however, it is concluded that institutional design factors limited the acceptance of such alternative.La coyuntura actual ha colocado en debate si la Constitución Económica Peruana habilita la intervención estatal en el mercado de medicamentos como solución ante el problema público del alza de precios de productos farmacéuticos durante el contexto de la Covid. En ese sentido, se analiza las iniciativas legislativas que plantearon diversas alternativas de solución, entre ellas, la regulación de precios de medicamentos; no obstante, se concluye que factores de diseño institucional limitaron que tal alternativa fuera acogida.